FDA Inspection 1018450 — James L. Campbell Jr, MD
The FDA completed an inspection of James L. Campbell Jr, MD on June 14, 2017 in Portsmouth, NH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 14, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Portsmouth, NH (United States)
Additional Details
Clinical Investigator (CI)